JP2015518827A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015518827A5 JP2015518827A5 JP2015512727A JP2015512727A JP2015518827A5 JP 2015518827 A5 JP2015518827 A5 JP 2015518827A5 JP 2015512727 A JP2015512727 A JP 2015512727A JP 2015512727 A JP2015512727 A JP 2015512727A JP 2015518827 A5 JP2015518827 A5 JP 2015518827A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence number
- sequence
- variable region
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261648391P | 2012-05-17 | 2012-05-17 | |
| US61/648,391 | 2012-05-17 | ||
| PCT/US2013/040827 WO2013173255A2 (en) | 2012-05-17 | 2013-05-13 | Antigen binding proteins that bind egfr |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015518827A JP2015518827A (ja) | 2015-07-06 |
| JP2015518827A5 true JP2015518827A5 (enExample) | 2016-06-30 |
| JP6441792B2 JP6441792B2 (ja) | 2018-12-19 |
Family
ID=49581478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015512727A Expired - Fee Related JP6441792B2 (ja) | 2012-05-17 | 2013-05-13 | Ｅｇｆｒに結合する抗原結合蛋白質 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9944707B2 (enExample) |
| EP (1) | EP2850105A4 (enExample) |
| JP (1) | JP6441792B2 (enExample) |
| CN (1) | CN104918956A (enExample) |
| CA (1) | CA2872018A1 (enExample) |
| HK (1) | HK1208474A1 (enExample) |
| WO (1) | WO2013173255A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10100118B2 (en) | 2015-04-08 | 2018-10-16 | Sorrento Therapeutics, Inc. | Antibody therapeutics that bind CD123 |
| EP3280442A4 (en) * | 2015-04-08 | 2018-10-31 | Sorrento Therapeutics, Inc. | Antibody therapeutics that bind cd123 |
| MX2018007406A (es) * | 2015-12-16 | 2018-08-15 | Merck Sharp & Dohme | Anticuerpos anti-lag3 y fragmentos de enlace al antigeno. |
| AR107505A1 (es) | 2016-01-22 | 2018-05-09 | Merck Sharp & Dohme | Anticuerpos anti-factor de la coagulación xi |
| EP3449939B1 (en) | 2016-04-27 | 2022-03-30 | Green Cross Corporation | Pharmaceutical composition for inhibiting metastasis of cancer, comprising, as active ingredient, antibody that specifically binds to epidermal growth factor receptor |
| KR102218714B1 (ko) | 2016-06-14 | 2021-02-24 | 머크 샤프 앤드 돔 코포레이션 | 항응고 인자 xi 항체 |
| EP3980448A4 (en) * | 2019-06-04 | 2023-06-28 | Academia Sinica | Ligands targed to epidermal growth factor receptors and compositions for use in treating tumors |
| WO2021035096A1 (en) * | 2019-08-20 | 2021-02-25 | Kumquat Biosciences Inc. | Compositions and methods for targeting cellular molecules |
| WO2022251575A1 (en) * | 2021-05-27 | 2022-12-01 | The United States Government As Represented By The Department Of Veterans Affairs | Human monoclonal antibodies specific to streptolysin o and methods of use |
| CA3243690A1 (en) * | 2022-02-04 | 2023-08-10 | Vivasor Inc | ANTIGEN-BINDING PROTEINS THAT BIND TO B7-H3 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU221001B1 (hu) * | 1994-03-17 | 2002-07-29 | Merck Patent Gmbh. | Egyláncú anti-EGFR Fv-k és anti-EGFR ellenanyagok |
| DE69738539T2 (de) | 1996-12-03 | 2009-03-26 | Amgen Fremont Inc. | Vollkommen humane Antikörper die EGFR binden |
| US6235883B1 (en) * | 1997-05-05 | 2001-05-22 | Abgenix, Inc. | Human monoclonal antibodies to epidermal growth factor receptor |
| US20020173629A1 (en) * | 1997-05-05 | 2002-11-21 | Aya Jakobovits | Human monoclonal antibodies to epidermal growth factor receptor |
| EP2111870A1 (en) | 1999-08-27 | 2009-10-28 | Genentech, Inc. | Dosages for treatment of anti-erbB2 antibodies |
| CZ200438A3 (cs) * | 2001-06-13 | 2004-06-16 | Genmab A/S | Název neuveden |
| US7595378B2 (en) | 2001-06-13 | 2009-09-29 | Genmab A/S | Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| SI1735348T1 (sl) * | 2004-03-19 | 2012-09-28 | Imclone Llc | Äśloveĺ ko anti-egfr protitelo |
| WO2005090407A1 (en) * | 2004-03-19 | 2005-09-29 | Imclone Systems Incorporated | Human anti-epidermal growth factor receptor antibody |
| EP2402374A1 (en) * | 2005-02-07 | 2012-01-04 | GlycArt Biotechnology AG | Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| US20060216288A1 (en) | 2005-03-22 | 2006-09-28 | Amgen Inc | Combinations for the treatment of cancer |
| WO2007058823A2 (en) | 2005-11-12 | 2007-05-24 | Eli Lilly And Company | Anti-egfr antibodies |
| US20100291593A1 (en) | 2007-07-13 | 2010-11-18 | Powell William C | Method of identifying diagnostic reagents |
| CN102164960A (zh) | 2008-09-26 | 2011-08-24 | 罗氏格黎卡特股份公司 | 双特异性抗-egfr/抗-igf-1r抗体 |
| JPWO2010087425A1 (ja) | 2009-01-30 | 2012-08-02 | 国立大学法人京都大学 | 前立腺癌の進行抑制剤および進行抑制方法 |
| AU2010230346A1 (en) | 2009-03-31 | 2011-07-28 | Roche Glycart Ag | Treatment of cancer with a humanized anti-EGFR IgG1antibody and irinotecan |
| ES2639056T3 (es) | 2009-10-28 | 2017-10-25 | Abbvie Biotherapeutics Inc. | Anticuerpos anti-EGFR y sus usos |
| JP5818003B2 (ja) | 2009-11-18 | 2015-11-18 | 国立大学法人東北大学 | ヒト型化抗ｅｇｆｒ抗体可変領域の高機能性変異体 |
| WO2011156617A2 (en) | 2010-06-09 | 2011-12-15 | Aveo Pharmaceuticals, Inc. | Anti-egfr antibodies |
| AU2011320314B2 (en) * | 2010-10-29 | 2015-08-06 | Immunogen, Inc. | Novel EGFR-binding molecules and immunoconjugates thereof |
| US8691231B2 (en) | 2011-06-03 | 2014-04-08 | Merrimack Pharmaceuticals, Inc. | Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies |
| TWI443108B (zh) | 2011-12-28 | 2014-07-01 | Ind Tech Res Inst | 抗人類表皮生長因子受體抗體及其應用 |
-
2013
- 2013-05-13 CA CA2872018A patent/CA2872018A1/en not_active Abandoned
- 2013-05-13 CN CN201380038496.5A patent/CN104918956A/zh active Pending
- 2013-05-13 US US13/893,312 patent/US9944707B2/en active Active
- 2013-05-13 HK HK15109023.5A patent/HK1208474A1/xx unknown
- 2013-05-13 EP EP13790813.3A patent/EP2850105A4/en not_active Withdrawn
- 2013-05-13 JP JP2015512727A patent/JP6441792B2/ja not_active Expired - Fee Related
- 2013-05-13 WO PCT/US2013/040827 patent/WO2013173255A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6829330B2 (ja) | Ｐｄ−ｌ１に結合する抗原結合蛋白質 | |
| JP6997743B2 (ja) | Ｐｄ－１に結合する抗原結合蛋白質 | |
| US11919952B2 (en) | Antigen binding proteins that bind PD-L1 | |
| US12084503B2 (en) | Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2) and methods of use thereof for treatment | |
| JP6441792B2 (ja) | Ｅｇｆｒに結合する抗原結合蛋白質 | |
| JP2015518827A5 (enExample) | ||
| CN105120890B (zh) | 与ErbB3结合的抗原结合蛋白 | |
| JP2015520172A (ja) | Ｄｌｌ−４に結合する抗原結合蛋白質 | |
| CN104411332B (zh) | 与vegfr2结合的全人抗体 | |
| JP6388576B2 (ja) | Ｉｇｆ１ｒに結合する抗原結合タンパク質 |